InsidersTradesSigma
Browse the detailed record of transactions filed by Tobias Larsson Agervald, 董事长兼首席执行官. Director active across 2 companies, notably Guard Therapeutics International AB (publ). In total, 2 reports have been published. History available since 4 April 2025. The latest transaction was disclosed on 15 May 2025 (Purchase). Regulator: FIN-FSA. All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 条申报中的 2 条
Tobias Larsson Agervald is the Chief Executive Officer of Guard Therapeutics International AB (publ). He leads the company with a strategic vision, focusing on innovation and treatment development. His role is essential for the growth of Guard Therapeutics, which specializes in innovative therapeutic solutions.